BTG (LON:BTG) has been on my watchlist for a while and just dropped below the threshold at which I had set an alert on it.
I haven't been paying it much attention recently, I can't even remember why I set the alert at that number so I'm out of touch with what is going on there.

Stocko gives It a rating of 29 due to low value and momentum indicators. The value rank seems low in part because of a P/E stated as 99 but the 12 month forecast forward P/E is only 17 which seems odd to me.

Looks like it could be entering a range where I think it might turn around and head up over the next 6 months but is anyone able to help me why it seems so out of favour? Is it worry about Trump policy on Pharma companies?

All thoughts welcome.

Unlock the rest of this article with a 14 day trial

Already have an account?
Login here